Recent advances in the therapy and prevention of CMV infections
- 2 February 2000
- journal article
- review article
- Published by Elsevier in Journal of Clinical Virology
- Vol. 16 (1) , 25-40
- https://doi.org/10.1016/s1386-6532(99)00065-7
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- Current antiviral strategies for controlling cytomegalovirus in hematopoietic stem cell transplant recipients: prevention and therapyTransplant Infectious Disease, 1999
- The Dynamics of Human Cytomegalovirus Replication in VivoThe Journal of Experimental Medicine, 1999
- Successful Modification of a pp65 Antigenemia-Based Early Treatment Strategy for Prevention of Cytomegalovirus Disease in Allogeneic Marrow Transplant RecipientsBlood, 1999
- Pharmacokinetics of Valganciclovir and Ganciclovir Following Multiple Oral Dosages of Valganciclovir in HIV- and CMV-Seropositive VolunteersClinical Pharmacokinetics, 1999
- Quantitation of Cytomegalovirus: Methodologic Aspects and Clinical ApplicationsClinical Microbiology Reviews, 1998
- Astudy of the pharmacokinetics, antiviral activity, and tolerability of oral ganciclovir for (MV prophylaxis in marrow transplantationTransplantation and Cellular Therapy, 1998
- Severe Cytomegalovirus Infection in Immunocompetent PatientsClinical Infectious Diseases, 1997
- Polymerase chain reaction monitoring reduces the incidence of cytomegalovirus disease and the duration and side effects of antiviral therapy after bone marrow transplantationBlood, 1995
- Oral Ganciclovir as Maintenance Treatment for Cytomegalovirus Retinitis in Patients with AIDSNew England Journal of Medicine, 1995
- Polymerase Chain Reaction to Detect Cytomegalovirus DNA in the Cerebrospinal Fluid of Neonates with Congenital InfectionThe Journal of Infectious Diseases, 1994